drugset / Trial / NCT00314626
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily
Phase 3
Completed
99 enrolled
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the proportion of patients with virological failure after 48 weeks of treatment with the combination of efavirenz 600 mg + lamivudine (3TC) 300 mg + abacavir 600 mg once daily as an antiretroviral simplification regimen.
Timeline
- Start
- 2004-11
- Primary completion
- 2007-02
- Completion
- 2007-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Abacavir | Other / unclassified | 600 mg | — |
| Subject | Efavirenz | Other / unclassified | 600 mg | — |
| Subject | Lamivudine | Other / unclassified | 300 mg | — |